Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.38Price to Book
VS
Market
Sector
Industry
History
$ 2.13Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 13.43M | $ 5.1M | 0.38 |
| 3/31/2025 | $ 7.02M | $ 2.75M | 0.39 |
| 12/31/2024 | $ 6.18M | $ 3.86M | 0.62 |
| 9/30/2024 | $ 8.4M | $ 3.65M | 0.43 |
| 6/30/2024 | $ 9.21M | $ 3.16M | 0.34 |
| 3/31/2024 | $ 11.1M | $ 2.23M | 0.2 |
| 12/31/2023 | $ 12.77M | $ 2.16M | 0.17 |
| 9/30/2023 | $ 9.58M | $ 2.03M | 0.21 |
| 6/30/2023 | $ 12.09M | $ 2.33M | 0.19 |
| 3/31/2023 | $ 12.39M | $ 3.86M | 0.31 |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 4.63.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average P/B has been 1.1.
- The median P/B for INMED PHARMACEUTICALS INC during this period was 0.41
- INMED PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 4.93.
- The lowest P/B recorded by INMED PHARMACEUTICALS INC in the same timeframe 0.17
INMED PHARMACEUTICALS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for INMED PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 20.83M ] / Equity [ $ 4.49M ]
(=) P/B [ 4.63 ] INM - Price to Book, Last 5 years
0.17
Minimum
Dec 31, 2023
4.93
Maximum
Dec 31, 2020
1.1
Average
0.41
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |